and white (73%), with a mean age of 52. Asthma was comorbid in 55%, and 16% had aspirin-exacerbated respiratory disease. As about 37% of participants had no prior nasal polyp surgeries ...

Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...

The monoclonal antibody against thymic stromal lymphopoietin (TSLP) improved total nasal-polyp score by a mean -2.07 points (95% CI −2.39 to −1.74) more than placebo on a 0-4 point scale at 52 ...